A former Volkswagen CEO Martin Winterkorn has been charged in the US with conspiracy and fraud over the car maker’s long-running scam to cheat emissions tests, two months after VW faced trial in Australia over dieselgate.
A Federal Court judge has shot down Kraft’s suggestion that his order blocking it from acting further in a US arbitration between it and Bega over peanut butter trade dress rights should only pertain to its claims and not Bega’s cross-claim.
The Australian Competition and Consumer Commission has asked the Federal Court to hit We Buy Houses and its owner Richard ‘Rick’ Otton with $20 million in penalties for duping aspiring property investors with claims that they would learn how to buy a home for $1.
“Embarrassing” is how Woolworths has described the ACCC’s claim that its line of environmentally-friendly disposable dishes doesn’t biodegrade in a reasonable amount of time.
A judge has thrown out a lawsuit by an international health food supplement maker that accused its former Australian distributor of passing off its own products to sell to Woolworths.
The long awaited second phase in the Australian Competition and Consumer Commission’s cartel proceedings against Air New Zealand has been set down for June 27, one year after the High Court ruled the airline had breached Australia’s competition law.
HP has agreed to refund customers in Australia after admitting it used secret software to block third-party ink cartridges from working on certain HP printers.
Johnson & Johnson has struck back at an amended statement of claim filed in a class action over allegedly defective pelvic mesh, saying that lead applicants’ claims do not meet the bar to proceed as a class action.
The Australian Competition and Consumer Commission is seeking more information from Pacific National and Aurizon on their proposed merger, after the regulator’s preliminary review found the deal raises significant competition concerns.
The Therapeutic Goods Administration is seeking feedback on its proposed process for handling advertising complaints when stricter new advertising rules for therapeutic products take effect later this year.